Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03576274 · ClinicalTrials.gov registry record · NA

Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors

A NA study of Exercise and Cancer-related Problem/Condition, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT03576274 is a NA study of Exercise and Cancer-related Problem/Condition that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 110 participants, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03576274, a NA study of Exercise and Cancer-related Problem/Condition, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

A 12 weeks technology enhanced home exercise (TEHE) program using mobile technologies that provide immediate feedback and send reminder messages to improve exercise motivation is developed. Investigators combine this TEHE program with techniques including auricular point pressure (APA) and brief mindfulness body scan (MBI). This study will examine the feasibility of the TEHE program and combined programs, and ascertain the effect of TEHE program alone, the combined programs on fatigue and biological markers among cancer survivors. Main Research Variable(s): The independent variables are the 12-week program of TEHE alone, APA alone, combined APA and TEHE (TEHEplus) and combined MBI and TEHE (TEHE-MBI). Outcome variables are fatigue, physical activity, contributing factors of fatigue and biomarkers. Design: Repeated measures randomized controlled trial. Setting: Participants will be recruited through the Comprehensive Cancer Center, Johns Hopkins University. Sample: Participants diagnosed with non-metastatic solid tumor cancer; who had completed all primary cancer treatment (surgery, chemotherapy, and radiation therapy )within at least 3 months OR non-metastatic prostate cancer completed all primary cancer treatment and have hormone therapy for at least 6 month, OR participants diagnosed with solid tumor cancer; who are receiving immunotherapy for at least 3 months before enrollment, aged 21 years or older, experiencing fatigue in the past 7 days on average of ≥ 3/10, able to participate in a moderate-intensity exercise training program, self-report ability to complete the 6 min walk test with a perceived exertion of 3 or below, and can communicate in English. Methods: Participants who meet the inclusion criteria will be randomly assigned to the TEHE only, APA only or TEHEplus or TEHE-MBI or control group. All exercise groups (TEHE) will be offered a 12-week exercise program through an online communication. In additional to the TEHE, the TEHEplus group will receiv

Interventions

  • BEHAVIORAL Technology Enhanced Home Exercise (TEHE)
  • BEHAVIORAL Auricular Point Acupressure (APA)
  • BEHAVIORAL Mindfulness body scan (MBI)

Study Locations (1)

Maryland

  • The Sidney Kimmel Comprehensive Cancer Center - Baltimore

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2019-10-10
Est. Completion 2024-09-15
Phase NA

What the Registry Record Tells You About NCT03576274

The ClinicalTrials.gov registry entry for NCT03576274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Exercise appearing as the primary indexed condition, and to 3 interventions - of which Technology Enhanced Home Exercise (TEHE) is the first listed.

NCT03576274 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03576274 about?

NCT03576274 is a clinical study titled "Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors". A 12 weeks technology enhanced home exercise (TEHE) program using mobile technologies that provide immediate feedback and send reminder messages to improve exercise motivation is developed. Investigators combine this TEHE program with techniques including auricular point pressure (APA) and brief min...

What is the current status of trial NCT03576274?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-10-10. Estimated completion is 2024-09-15.

What conditions does trial NCT03576274 study?

This clinical trial studies the following conditions: Exercise, Cancer-related Problem/Condition, Acupressure.

What interventions are being tested in trial NCT03576274?

The interventions under investigation include: Technology Enhanced Home Exercise (TEHE) (BEHAVIORAL), Auricular Point Acupressure (APA) (BEHAVIORAL), Mindfulness body scan (MBI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03576274?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03576274 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.